Long-Term Clinical Outcomes in Patients With Transthyretin Cardiac Amyloidosis Versus Non-Ischemic Cardiomyopathy
In this retrospective study from a large healthcare system database, compared to NICM, transthyretin CA patients had significantly higher rates of HFH, similar odds of VTA, and a lower likelihood of receiving an intracardiac device.
Authors
- Mina M. Benjamin (ORCID: https://orcid.org/0000-0001-9076-2321)
- Timothy Chrusciel (ORCID: https://orcid.org/0009-0005-6923-0781)
- Barbara Okeke
Institutions
- Saint Louis University Hospital (US)
- Saint Louis University (US)
Publication Details
- Journal
- Cardiology Research
- Published
- 2025-02-28
- DOI
- https://doi.org/10.14740/cr2050
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00